Effects of Upper Extremity-Focused Neuromuscular Training in People With Multiple Sclerosis
1 other identifier
interventional
72
0 countries
N/A
Brief Summary
The effectiveness of upper extremity focused neuromuscular exercise training in early stage people with MS will be investigated. People with MS enrolled in the study will be randomly assigned to three groups: Neuromuscular Exercise Group (NEG), Conventional Exercise Group (CEG), and Control Group (CG). All three groups will be assessed with primary and secondary outcome measures at baseline, week 8, and week 12. NEG, CEG, and CG will be initially assessed for upper extremity function, cognitive function, lower extremity function, grip strength, proximal muscle strength, sensation, coordination, fatigue, postural sway, and core muscle strength and endurance. Then, NEG will receive clinically supervised upper extremity focused neuromuscular exercise training with a minimum of 60 minutes of session time, 2 days a week for 8 weeks. This exercise training includes steps for postural control, weight transfer, proximal and distal muscle strengthening, proprioception, coordination and reaction speed. Similarly, CEG will receive clinically supervised traditional upper extremity exercise training, twice a week for 8 weeks, with a minimum of 60 minutes of session time. This exercise training includes strengthening with the band and manuel dexterity exercises. In both groups, stretching and mobility exercises will be added to the warm-up and cool-down exercises before and after the program. During this process, CG will be on the waiting list. At the end of 8 weeks, all three groups will be re-evaluated. After the exercise training, follow-up will be done and evaluations will be repeated in the 12th week. This study will provide evidence on the effects of upper extremity-focused neuromuscular exercise training on physical and cognitive functions in early-stage people with MS compared to traditional treatment approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Nov 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2024
CompletedStudy Start
First participant enrolled
November 30, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2025
CompletedDecember 4, 2024
December 1, 2024
11 months
November 26, 2024
December 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Nine Hole Peg Test
To assess unilateral function of the upper extremity
At the beginning, at the end of 8 weeks and 12 weeks
Minnesota Manual Dexterity Test
To assess bilateral upper extremity function
At the beginning, at the end of 8 weeks and 12 weeks
Manual Ability Measure-36
To assess upper extremity function. A higher score indicates better hand function.
At the beginning, at the end of 8 weeks and 12 weeks
Timed 25-Foot Walk
To assess lower extremity function
At the beginning, at the end of 8 weeks and 12 weeks
Symbol Digit Modalities Test
To assess cognitive function
At the beginning, at the end of 8 weeks and 12 weeks
Hand Dynamometer
To assess hand grip strength
At the beginning, at the end of 8 weeks and 12 weeks
Secondary Outcomes (7)
Hand Held Dynamometer
At the beginning, at the end of 8 weeks and 12 weeks
Biodex Balance System
At the beginning, at the end of 8 weeks and 12 weeks
Laser-pointer Assisted Angle Reproduction Test
At the beginning, at the end of 8 weeks and 12 weeks
Finger Tapping Test
At the beginning, at the end of 8 weeks and 12 weeks
Fatigue Severity Scale
At the beginning, at the end of 8 weeks and 12 weeks
- +2 more secondary outcomes
Study Arms (3)
NEG
EXPERIMENTALUpper Extremity Focused Neuromuscular Exercise Training
CEG
ACTIVE COMPARATORTraditional Upper Extremity Exercise Training
CG
NO INTERVENTIONControl Group
Interventions
This group will receive neuromuscular exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks. Warm-up Program - 5 minutes Postural Control-Weight Transfer - 10-15 minutes Strength Training - 30-35 minutes Proprioception - Coordination - Reaction Speed 10-15 minutes Cool-down Program - 5 minutes
This group will be given traditional strength exercise training consisting of 60-75 minute sessions per day, 2 days per week for 8 weeks. Warm-up Program - 5 minutes Strength Training - 30-35 minutes Manuel Dexterity - 15-20 minutes Cool-down Program - 5 minutes
Eligibility Criteria
You may qualify if:
- Definite MS according to McDonald criteria,
- years
- RRMS,
- EDSS \< 4,
- Minimal or moderate upper extremity involvement
You may not qualify if:
- Having an attack in the last three months,
- Mini Mental Test \<24 or visual deficit,
- Other medical conditions accompanying MS (cardiac, orthopedic or rheumatic, etc.),
- Being pregnant or breastfeeding,
- Doing regular exercise - receiving physiotherapy,
- Having spasticity of 2 or more in the upper extremity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Uğur Ovacık
Istanbul Aydın University
- STUDY DIRECTOR
Ela Tarakcı
Istanbul University - Cerrahpasa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PT, MSc
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 2, 2024
Study Start
November 30, 2024
Primary Completion
November 1, 2025
Study Completion
December 29, 2025
Last Updated
December 4, 2024
Record last verified: 2024-12